Navigation Links
Approved cancer drug potentially could help treat diabetes, Stanford researchers find
Date:9/15/2013

STANFORD, Calif. A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway a series of interaction among proteins involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.

The findings will be published online Sept. 15 in two articles in Nature Medicine.

The studies, done in mice, identify a previously unexpected link between a low-oxygen condition called hypoxia and the ability of cells in the liver to respond to insulin. The drug, aflibercept (marketed as Eylea or Zaltrap), is used to treat metastatic colorectal cancer and a form of macular degeneration. Aflibercept is a member of a family of proteins that inhibit the vascular endothelial growth factor, or VEGF, pathway. It works by blocking the growth of the blood vessels into tumors and starving them of oxygen.

The lab of Calvin Kuo, MD, PhD, professor of medicine, identified a series of protein interactions that link VEGF inhibitors and blood glucose levels. "We were surprised to find that this drug currently used in patients for cancer treatment had beneficial effects on diabetes in laboratory mice and could, potentially, in humans," said Kuo, senior author of one of the Nature Medicine papers.

Amato Giaccia, PhD, the Jack, Lulu and Sam Willson Professor of Cancer Biology, is senior author of the other paper. "Proteins involved in this pathway could also be targeted for the development of new diabetes therapies," said Giaccia, who also is a professor and director of radiation oncology. His laboratory has identified a protein called PhD3 that could be a particularly attractive target.

The lead author of the Giaccia paper is Cullen Taniguchi MD, PhD, a radiation oncology resident at Stanford; former graduate students Kevin Wei, MD, PhD, and Lisa McGinnis, MD, PhD, and postdoctoral scholar Stephanie Piecewicz, PhD, a
'/>"/>

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. ASHA Approved Continuing Education Provider Announces Schedule Of Live Speech-Language Pathology Webinars
2. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Boehringer Ingelheim’s Application to Expand Approved Uses for Pradaxa
3. The Florida House Experience Approved for Expansion of Their Comprehensive Addiction Detox Program in Deerfield Beach, FL
4. Diet Doc Medical Weight Loss Plans Issues New Advice For Patients Looking to Avoid Long Term Health Risks Associated With New FDA Approved Diet Pills
5. New Online Vestibular Rehabilitation course approved for PT continuing education in California
6. Gentek Building Products, Inc. Class Action Settlement Approved, Reports Parker Waichman LLP, Adding that Partner Jordan L. Chaikin Has Been Appointed Settlement Class Counsel
7. Approved NJ Top Doc Dr. Michelle O’Shea Hosts "Celebrate You"—A Breast Cancer Survivor Event
8. FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery
9. FDA Approved Home Ultrasound Machine Discounted Online
10. Myrtle Beach Urology Groups Administer First Commercial Dose of Newly FDA Approved Prostate Cancer Treatment
11. SafeToSleep Baby Monitor Wins Parent Tested Parent Approved (PTPA) Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... November 28, 2014 Dr. Paul Vitenas, one of ... a Glitter & Glow Holiday Event for those in the area ... at his practice. Glitter & Glow will take place on December ... new location in the heart of Houston at 4208 Richmond Ave. ... and hope that you will come and celebrate the season with ...
(Date:11/28/2014)... Evergreen, Colorado (PRWEB) November 28, 2014 Written ... Jackson , Brook Forest Voices releases the “The Happiest ... audiobook , a compelling account of how and why Project ... of Idaho by his mother Josie and the Reverend Richard ... millionaire by the age of 30, but realized that he ...
(Date:11/28/2014)... Alex Kramer HealthDay Reporter , ... in the kitchen, through cooking classes or at home, may ... a recent review. Cooking programs and classes for children ... to the new research. And, although the review didn,t look ... such programs might help children develop long-lasting healthy habits. ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, ... filling and it was almost impossible to reach. "This gave ... said. , The patent-pending Access Light allows for easier use ... of the mouth, as well as avoids harm to the ... to use and clean, it also helps prevent cross-contamination. , ...
(Date:11/28/2014)... 28, 2014 More than 2,100 ... been filed in a New Jersey litigation that ... Liebhard LLP reports. , A Case List ... Court reflects the filing of 2,160 claims over ... which were voluntarily recalled on July 6, 2012 ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3
... Welcome to syngo® .plaza(1), ... Healthcare. As the first Picture Archiving and Communications System ... in one place, syngo .plaza is poised to ... at the 95th Scientific Assembly and Annual Meeting of the Radiological ...
... affect circadian rhythm, , FRIDAY, Nov. 27 (HealthDay News) -- ... on the fritz could be a factor in the development ... from the examination of the genetic makeup of 152 children ... mood swings, and 140 children without the disorder. They linked ...
... BC, Nov. 27 /PRNewswire/ - Uploadable USB pedometers may ... wellness. A combination of advanced accelerometer functionality and automated ... the accuracy of self-reported data. It,s now possible to ... program. , CoreHealth Technologies is one of the first ...
... , SAN FRANCISCO, Nov. 27 The Gymboree Corporation (Nasdaq: ... the NASDAQ OMX 23rd Investor Program, which will be held at ... 2009, at 11:45 a.m. GMT. , To listen to a live ... on to www.gymboree.com, click on "Our Company" at the bottom of ...
... Nov. 27 Shamir Optical Industry Ltd. (Nasdaq: SHMR ... and technology to the ophthalmic lens market, announced today that ... an aggregate amount of US$ 10 million (approximately NIS 37.62 ... exchange), or approximately US$ 0.609 (approximately NIS 2.3 based on ...
... rates to bring unprecedented medical, economic burdens, study predicts , ... with diabetes in the United States is expected to double ... That would bring the total by 2034 to about 44.1 ... , , At the same time, the cost of treating ...
Cached Medicine News:Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
(Date:11/28/2014)... CITY, Kan. , Nov. 28, 2014 ... therapeutics company focused on the licensing or acquisition, development ... and other companion animals, today announced that it will ... Healthcare Conference, to be held December 2-3, 2014, at ... York . Steven St. Peter ...
(Date:11/28/2014)... 30 September 201430 September 2013Turnover 546,011 , 534,641 , ... , 339,113 , 13.3 Hospital Management Service ... 49.5 Medical Insurance Administration Service Income , 2,394 ... Sales , 94,580 , 142,683 , ... 9,219 , (68.4) Impairment Loss on Fixed Assets ...
(Date:11/26/2014)... 2014  Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, said today ... On Tuesday, December 2, the company will ... Healthcare Conference.  D. Keith Grossman , President and ... company beginning at 11:30 a.m., Eastern Standard Time (8:30 ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Thoratec Announces Presentations At Investor Conferences For December 2014 2
... Mass., Oct. 11, 2011 Merrimack Pharmaceuticals, Inc. ... dosed in a randomized Phase 2 clinical trial ... targets ErbB3, combined with paclitaxel (Taxol®) in the ... (Logo: http://photos.prnewswire.com/prnh/20100913/NE63515LOGO) The Phase 2 ...
... BEIJING, Oct. 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... leading China-based advanced in-vitro diagnostic ("IVD") company, today announced ... Kingdom Intellectual Property Office (the "UKIPO") and Notice of ... Patent and Trademark Office (the "USPTO"). All patents relate ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients 2China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO 2China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO 3
... only medical grade DVD recorder that features a ... exclusive features DVORECOVERY™ and DVOFAST™, making this recorder ... designed. DVORECOVERY enables the end user to re-capture ... DVOFAST enables you to remove a recorded disk ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
... Freedom EVOlyzer is Tecans new Enzyme Immuno ... processing. Freedom EVOlyzer is a dedicated EVO ... state-of-the art reader, washer and incubation units ... The Freedom EVOlyzer is available in three ...
... Introducing the ADVIA Centaur CP* the performance ... compact but powerful package. Available in a benchtop ... 29" (107 x 74 cm), the ADVIA Centaur ... the growing needs of your lab with optimal ...
Medicine Products: